About Us

About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Septerna Appoints Jeffrey Finer, MD, PhD, as Chief Executive Officer

By: via Business Wire

Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that Jeffrey Finer, MD, PhD, has been named the company’s full-time Chief Executive Officer, transitioning from his current role as interim CEO.

“We are excited that Jeff will continue his role with Septerna as its full-time CEO, continuing the company’s significant momentum advancing its emerging pipeline of novel GPCR therapies and Native Complex™ platform, and growing a fantastic team,” said Jeffrey Tong, PhD, Chairman of the Board of Septerna and Partner at Third Rock Ventures. “Jeff’s deep experience in both company building and R&D leadership make him perfectly suited to lead Septerna and I can’t wait to see what he and the team are able to do in the coming years.”

Septerna was launched in January of 2022 with a $100 million Series A financing led by Third Rock Ventures. The company was founded to leverage its Native ComplexTM platform to overcome historic challenges of reaching the vast untapped potential of GPCR drug targets for a wide range of diseases. Under Jeff’s leadership, Septerna has built a powerful drug discovery engine and has advanced a rapidly growing early pipeline of novel GPCR drug candidates.

“We’ve made great early progress as a young company, delivering on the potential of our platform and building the right team to fully maximize it for the benefit of patients,” said Finer. “Our technology is allowing us to develop novel insights into GPCR target modulation at a rate that is unprecedented in the industry, and this is fueling our advancing portfolio of drug discovery programs. I’m thankful and thrilled to be able to continue leading our talented team of drug hunters as we all work towards the goal of advancing next-generation GPCR medicines for patients.”

Dr. Finer brings more than 35 years of research, clinical and business experience in senior leadership roles and has focused his career on breakthrough innovations that have included moving several first-in-class drugs into the clinic, developing novel technology platforms which integrate science and engineering, and company creation. In addition to being a Co-founder of Septerna, Jeff has helped create and launch multiple new biotech companies, including Maze Therapeutics and Ambys Medicines, and he has held R&D leadership positions at Theravance Biopharma, Five Prime Therapeutics, and Cytokinetics. Jeff has current roles on the boards of Strateos, Ambys, and Maze, and will continue as a Venture Partner at Third Rock. A full biography is available here.

About Septerna

Septerna, Inc. is a biotechnology company creating broad new drug discovery opportunities across many disease areas for the abundant drug target class of G protein-coupled receptors (GPCRs). The company’s Native Complex™ Platform recapitulates GPCRs with their native structure, function, and dynamics outside of the cellular environment to enable new technologies for industrial-scale drug discovery for the entire GPCR target class for the first time. Septerna has an emerging pipeline of GPCR-targeted small molecule drug discovery programs, along with growth potential to reach many GPCRs that have been undruggable and unexploited to date. Septerna was launched in 2022 by scientific founders who have made groundbreaking GPCR discoveries and by founding investor Third Rock Ventures. For more information, please visit www.septerna.com.

Contacts

More News

View More
3 Overlooked Value Stocks Set to Surge as Rates Drop
Via MarketBeat
Topics Artificial Intelligence Economy
Tickers CAVA CMG LULU UPS
Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
Via MarketBeat
Topics Economy
Tickers HIMS
After the Fed's Rate Cut, PNC Could See a Mortgage Refinance Boom
Via MarketBeat
Topics Economy
Tickers PNC
AIRO Group's Pullback: An Undervalued Growth Opportunity?
Via MarketBeat
Topics Supply Chain
Tickers AIRO
Caterpillar Stock Hits All-Time High—Is There More Room to Run?
Via MarketBeat
Topics Artificial Intelligence Economy World Trade
Tickers CAT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.